10 Most Promising Healthcare Stocks According to Wall Street Analysts
The US healthcare sector has trailed the broader market for three consecutive years, returning just 0.3% in 2023, 0.9% in 2024, and 12.5% in 2025.
Rhythm Pharmaceuticals Inc. (RYTM)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 6,666,837 | $579,814,814 | 6.14% | |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 5,604,483 | $487,421,887 | 2.8% | |
| 3. | Perceptive Advisors Joseph Edelman | 2,373,795 | $206,448,951 | -7% | 4.03% |
| 4. | Polar Capital Brian Ashford-Russell And Tim Woolley | 1,615,586 | $140,507,514 | +37% | 0.5% |
| 5. | Citadel Investment Group Ken Griffin | 1,418,619 | $123,377,295 | +826% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.17 | 10,000 | $201,713.00 | 111,335 | 2021-03-30 | Filing | |
| $26.42 | 378,501 | $9,999,996.42 | 3,074,893 | 2018-06-25 | Filing | |
| $17.00 | 100,000 | $1,700,000.00 | 2,696,392 | 2017-10-10 | Filing | |
| $17.00 | 100,000 | $1,700,000.00 | 2,696,392 | 2017-10-10 | Filing | |
| $17.00 | 550,000 | $9,350,000.00 | 4,909,956 | 2017-10-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $92.21 | 4,643 | $428,131.03 | 0 | 2026-05-15 | Filing | |
| $89.56 | 5,614 | $502,789.84 | 160 | 2026-03-04 | Filing | |
| $103.28 | 585 | $60,420.44 | 110,512 | 2026-02-19 | Filing | |
| $102.10 | 800 | $81,676.08 | 111,097 | 2026-02-19 | Filing | |
| $100.92 | 1,692 | $170,754.78 | 111,897 | 2026-02-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,237,151 | $542,445,023 | 0.01% | |
| 2. | 3,417,509 | $297,220,757 | 0.23% | |
| 3. | 3,040,718 | $264,451,244 | 0.01% | |
| 4. | 2,967,825 | $258,111,740 | 0% | |
| 5. | 2,271,851 | $197,582,881 | 0.01% |
News See All
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Rhythm Pharmaceuticals First Quarter 2026 Earnings Conference Call.
Billionaire Joe Edelman's 10 Stock Picks with Huge Upside Potential
Joseph Edelman, the billionaire chief of New York-based Perceptive Advisors, specializes in the biotechnology and life sciences sectors.
Is Rhythm Pharmaceuticals, Inc. (RYTM) A Good Stock To Buy Now?
Is RYTM a good stock to buy? We came across a bearish thesis on Rhythm Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bears’ thesis on RYTM.
15 Most Promising Stocks Under $100 to Buy
On March 12, Roger Ferguson, former Fed Vice Chair, joined 'Closing Bell' on CNBC to discuss what to expect from the Federal Reserve next week.
Top 10 Boring Stocks That Make Money
Investors have been concentrating on businesses with solid fundamentals, steady cash flows, and long-lasting competitive advantages that can produce steady profit growth in a market influenced by fluctuating...
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2025 Earnings Call Transcript
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2025 Earnings Call Transcript February 26, 2026Rhythm Pharmaceuticals, Inc. beats earnings expectations.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2025 Earnings Call Transcript
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2025 Earnings Call Transcript November 4, 2025Rhythm Pharmaceuticals, Inc. misses on earnings expectations.
Should You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
10 Hot Mid Cap Stocks to Buy Now
On Friday, August 29, stocks declined as investors decided to take some money out before a long weekend.
Hedge Fund Resource Center